Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

Université de Montréal

$25,000.00

Novel approach for T-cell genetic editing

FY 2017-18

Summary
Recent advances in biotechnology allow for the genetic modification of animal and human cells forapplications in research and medicine. This field is extremely promising and is likely to change how research isperformed and how therapies are designed in the future, notably by using cells as medicines. This might beespecially true for T cells, a subset of immune cells capable to fight refractory infections and certain cancers.This project matches a novel approach to genetically engineer cells (developed by Feldan, a biotechnologycompany) with the T-cell handling expertise developed at the University of Montréal. Specifically, theprincipal objective of this application is to develop and validate the best method to genetically engineer T cellsusing a Feldan product; the Shuttle. The Shuttle allows for the delivery of a cargo within the nucleus of the cell,where the genetic material is located. This transport is non-traumatic to the cell and as such may represent amarked advantage compared to competing approaches in the field. We will thus use the Shuttle to carryproteins capable to precisely modify the genetic code of cells (commonly referred as the CRISPR/Cas9system). Although the Shuttle can be used to genetically engineer several cell types, Feldan has no experienceusing it in T cells. The Delisle laboratory at the University of Montréal will provide this expertise and benefitfrom the Shuttle technology to advance the development of T-cell research. The project has two main aims;1-to optimize Shuttle-based cargo transfer methods to the nucleus of T cells in culture and 2- to provide aproof-of-principle of genetic editing in T cells. This work will enable Feldan and the Delisle laboratory toobtain key data to leverage additional funding towards the goal of positioning the Shuttle technology in theexpanding field of T-cell editing.
Program
Engage Grants Program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
516116-2017
Name nom
Delisle, JeanSébastien
Department département
Médecine
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5305
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Protein manipulation and expression
Research subject fr
Expression et recombinaison protéiques
Partie
1
Nb partie
1
Application title
Novel approach for T-cell genetic editing
Keyword
NSERC
Application summary
Recent advances in biotechnology allow for the genetic modification of animal and human cells forapplications in research and medicine. This field is extremely promising and is likely to change how research isperformed and how therapies are designed in the future, notably by using cells as medicines. This might beespecially true for T cells, a subset of immune cells capable to fight refractory infections and certain cancers.This project matches a novel approach to genetically engineer cells (developed by Feldan, a biotechnologycompany) with the T-cell handling expertise developed at the University of Montréal. Specifically, theprincipal objective of this application is to develop and validate the best method to genetically engineer T cellsusing a Feldan product; the Shuttle. The Shuttle allows for the delivery of a cargo within the nucleus of the cell,where the genetic material is located. This transport is non-traumatic to the cell and as such may represent amarked advantage compared to competing approaches in the field. We will thus use the Shuttle to carryproteins capable to precisely modify the genetic code of cells (commonly referred as the CRISPR/Cas9system). Although the Shuttle can be used to genetically engineer several cell types, Feldan has no experienceusing it in T cells. The Delisle laboratory at the University of Montréal will provide this expertise and benefitfrom the Shuttle technology to advance the development of T-cell research. The project has two main aims;1-to optimize Shuttle-based cargo transfer methods to the nucleus of T cells in culture and 2- to provide aproof-of-principle of genetic editing in T cells. This work will enable Feldan and the Delisle laboratory toobtain key data to leverage additional funding towards the goal of positioning the Shuttle technology in theexpanding field of T-cell editing.